KURE Holdings Information

KURE is an equity ETF with a total of 52 individual holdings. The top holdings are BeOne Medicines AG stock at 9.07%, Innovent Biologics at 7.42%, Jiangsu Hengrui Medicine at 7.38%, WuXi Biologics at 6.53%, and Sino Biopharmaceutical at 4.86%.

Total Holdings

Top 10 Percentage

54.78%

Asset Class

Equity

ETF Category

China Region

Assets

109.24M

PE Ratio

29.41

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	HKG: 6160	BeOne Medicines AG	9.07%	367,418
2	HKG: 1801	Innovent Biologics, Inc.	7.42%	625,000
3	SHA: 600276	Jiangsu Hengrui Medicine Co., Ltd.	7.38%	806,908
4	HKG: 2269	WuXi Biologics (Cayman) Inc.	6.53%	1,474,635
5	HKG: 1177	Sino Biopharmaceutical Limited	4.86%	4,643,750
6	SHE: 300760	Shenzhen Mindray Bio-Medical Electronics Co., Ltd.	4.35%	140,255
7	SHA: 603259	WuXi AppTec Co., Ltd.	4.14%	302,320
8	HKG: 1530	3SBio Inc.	3.87%	915,500
9	HKG: 9926	Akeso, Inc.	3.76%	228,000
10	HKG: 1093	CSPC Pharmaceutical Group Limited	3.41%	2,610,889
11	HKG: 3692	Hansoh Pharmaceutical Group Company Limited	2.62%	576,000
12	SHA: 688271	Shanghai United Imaging Healthcare Co., Ltd.	2.38%	120,533
13	SHA: 600436	Zhangzhou Pientzehuang Pharmaceutical., Ltd	2.34%	88,934
14	SHE: 300015	Aier Eye Hospital Group Co., Ltd.	2.21%	1,335,763
15	SHE: 000538	Yunnan Baiyao Group Co.,Ltd	2.00%	260,223
16	HKG: 2359	WuXi AppTec Co., Ltd.	1.93%	144,084
17	HKG: 6990	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	1.45%	23,600
18	HKG: 1099	Sinopharm Group Co. Ltd.	1.41%	647,600
19	SHE: 000963	Huadong Medicine Co., Ltd	1.39%	254,741
20	n/a	SICHUAN BIOKIN P	1.38%	29,521
21	SHA: 600196	Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	1.23%	300,829
22	HKG: 1548	Genscript Biotech Corporation	1.17%	570,000
23	SHE: 002294	Shenzhen Salubris Pharmaceuticals Co., Ltd.	1.17%	162,765
24	LEGN	Legend Biotech Corporation	1.16%	37,115
25	SHE: 002422	Sichuan Kelun Pharmaceutical Co., Ltd.	1.14%	226,215

As of Sep 9, 2025

Showing 25 of 52 holdings

Subscribe to see the full list

Upgrade Now